GPC3-CART cells

BIOLOGICAL2 trials

Sponsors

Shanghai GeneChem Co., Ltd., Chinese PLA General Hospital

Conditions

Carcinoma, HepatocellularHepatocellular Carcinoma (HCC)

Phase 1

A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)

Shanghai GeneChem Co., Ltd.Carcinoma, Hepatocellular

Start: 2017-04-01End: 2018-03-31Target: 10Updated: 2017-04-26

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Not yet recruitingNCT06641453

Chinese PLA General HospitalHepatocellular Carcinoma (HCC)

Start: 2024-11-15End: 2028-11-15Target: 30Updated: 2024-10-16